Immunotargets And Therapy impact factor, indexing, ranking (2024)

Aim and Scope

The Immunotargets And Therapy is a research journal that publishes research related to Immunology and Microbiology; Medicine. This journal is published by the Dove Medical Press Ltd.. The ISSN of this journal is 22531556. Based on the Scopus data, the SCImago Journal Rank (SJR) of immunotargets and therapy is 1.681.

Also, please check the following important details about immunotargets and therapy: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Immunotargets And Therapy Ranking

The Impact Factor of Immunotargets And Therapy is N/A.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

immunotargets and therapy Indexing

The immunotargets and therapy is indexed in:

• UGC CARE
• Scopus
• Web of Science (ESCI)
• DOAJ
• PubMed

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.

Immunotargets And Therapy Impact Factor 2024

The latest impact factor of immunotargets and therapy is N/A.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.

Immunotargets And Therapy Quartile

The latest Quartile of immunotargets and therapy is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

Publication fee

According to journal website, the publication fee of immunotargets and therapy is around 2390 USD.

The immunotargets and therapy has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.

Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Immunotargets And Therapy?

If your research is related to Immunology and Microbiology; Medicine, then visit the official website of immunotargets and therapy and send your manuscript.

Tips for publishing in Immunotargets And Therapy:

• Selection of research problem.
• Presenting a solution.
• Designing the paper.
• Make your manuscript publication worthy.
• Write an effective results section.
• Mind your references.

Acceptance Rate

Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the immunotargets and therapy publishes research articles in 16 weeks on an average.

Final Summary